# Partnerships and collaborations on vaccine development and evaluation

Source: https://www.keypedia.com/records/uk_mhra_guidance/uk-mhra/a8525708-80c0-4db0-b53e-b525e97d4cae
Type: Detailed Guide
Published: May 19, 2024
Updated: July 16, 2024

> The Vaccine Development and Evaluation Centre (VDEC), a division of the UK Health Security Agency (UKHSA), serves as a strategic partner for the advancement, assessment, and delivery of vaccines and therapeutic products. Collaborating with industry, academia, and government, VDEC supports the lifecycle of medical products from initial assay development through clinical trials to final market licensure. Although the provided text describes VDEC's capabilities rather than an enforcement action, it highlights the organization's role within global regulatory and research frameworks. VDEC is an approved partner for the US Government’s Biomedical Advanced Research and Development Authority (BARDA) for animal model development and medical countermeasure testing. It also serves as an implementing partner for the Coalition of Epidemic Preparedness Innovations (CEPI) and is a member of the UK’s National Immunisation Schedule Evaluation Consortium (NISEC). Because this document is an overview of services and partnerships, there are no inspection dates, regulatory violations, or required corrective actions mentioned. The regulatory focus is on supporting pharmaceutical companies in meeting the necessary standards for clinical evaluation and product authorization. Organizations seeking to develop vaccines or antimicrobial treatments are invited to contact UKHSA to utilize VDEC’s expertise in high-containment modeling and clinical trial support.

---

## Content

The Vaccine Development and Evaluation Centre ( VDEC ) works across sectors to build, evaluate and deliver vaccines and therapeutic products. Partner with VDEC We work with industry, academia and government. Contact UKHSA today to see how we can help you. Get in touch Why work with VDEC VDEC is an established partner for vaccine development. VDEC is: an approved partner for ‘Animal Model Development and Medical Countermeasure Testing’ in the US Government’s Biomedical Advanced Research and Development Authority ( BARDA ) non-clinical studies network an implementing partner for the Coalition of Epidemic Preparedness Innovations ( CEPI ) providing expertise in ‘High Containment Animal Modelling to Support Product Development’ a leading partner and provider of materials for CEPI ’s Central Laboratory Network a member of the UK’s National Immunisation Schedule Evaluation Consortium ( NISEC ) a participant in the UK Vaccine Network a member of the Delivery Partner Network for the Pathways to Antimicrobial Clinical Efficacy (PACE) programme a service provider to biotech and pharma companies, working on products through supporting assay development for clinical trials and onto licensure